Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical compositions and methods for managing skin conditions

a technology of compositions and pharmaceutical compositions, applied in the direction of drug compositions, biocides, detergent compounding agents, etc., can solve the problems of unprepared and used antimicrobial agents, unprepared stable compositions of hydrogen peroxide, hydroxy acids, etc., to prevent or treat skin conditions and cleanse the skin

Inactive Publication Date: 2006-03-09
MURAD HOWARD
View PDF23 Cites 47 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0077]Escherichia coli (ATCC # 8739), Staphylococcus pureus (ATCC # 6533), Pseudomonas aeruginosa (ATCC # 9027) were each propagated in Trypicase Soy Broth (TSB) at 35° C. for 24 hrs. Candida albicans (ATCC # 10231), and Aspergillus niger (ATOC # 16404) were propagated in Yeast and Mold Broth (YM) at 24° C. for 72 h. One loop of each bacteria culture was streaked onto Trypticase Soy Agar (TSA) and the yeast and mold onto Sabouraud Dextrose Agar (SDA). The bacterial and yeast cultures were incubated for 24 h at 35° C. and 48 h at 24° C., respectively. The mold culture was incubated for 5 days at 24° C. Following appropriate incubation, the surface growth of the organisms were washed with sterile Saline TS. Additional saline was added to reduce the microbial count. Each respective cell suspension was further diluted with sterile saline TS to an appropriate concentration.
[0079] Five 20-g portions of the Advanced Acne Prone Skin Formula of Example 2 was aseptically placed into sterile bottles. Each bottle was independently inoculated with 0.1 mL of the inoculum suspension.
[0081] A final concentration of 105 and 106 cfu / g of product was obtained. This spike suspension was assayed for each respective organism to determine the initial microbial load in the product. All enumeration analyses were performed by preparing serial 10-fold dilutions in Butterfield's Phosphate Buffered Diluent (BPBD), and then plated using the pour plate technique on respective media.
[0083] An enumeration of the target organisms were performed on each inoculum. Immediately after inoculation (less than 1 minute), each product was assayed to determine the density of viable target organisms according to the pour plate technique. Each sample was tested again after 2 and 4 minutes. A 1-g portion was removed and mixed with 9.9 mL of BPBD. Serial dilutions were prepared as appropriate. Test samples containing bacterial cultures were plated with TSA and incubated for 48 h at 35° C. Samples containing yeast and mold were plated with SDA and incubated for 5 days at 24° C.
[0085] The following results were obtained for each of the five organisms.
[0087] Theoretical Inoculum Level: 400,000 cfu / g TestingScheduleRecovery Levels (cfu / g)(Time: minutes)Advanced Acne Prone Skin Formula0 (less than 1)<102<104<10

Problems solved by technology

These functions are detrimentally affected by, for example, dryness, yeast, and structural changes in the skin, such as due to aging and excessive sun exposure.
Despite these references, a stable composition of hydrogen peroxide, a hydroxy acid, and an antimicrobial agent has not been prepared and used for cleansing skin and managing skin conditions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

Skin Cleanser Formulation

[0066] A pharmaceutical composition according to the invention may be prepared for cleansing skin as set forth below:

IngredientTrade Name / Supplier% by WeightPart ADeionized WaterN / A49.2Trisodium Ethylene-Diamine-HAMP-ENE Na3T / Akzo Nobel0.2Tetraacetic Acid (EDTA)Sodium Laureth-13SURFINE WLL / Finetex10CarboxylateDisodium LaurethMACKANATE EL / McIntyre17SulfosuccinateGroupDisodium CocoamphodiacetateMONATERIC CDX-38 / Mona11PEG-150 PentaerythritylCROTHIX / Croda1.5TetrastearatePEG-150 DistearateKESSCO PEG 6000 DS / Stepan.7MethylparabenN / A0.2Part BSalicylic AcidSalicylic Acid, powder,1.6USP / SpectrumCitric AcidN / A1.5TriclosanIRGASAN DP300 / Ciba0.3Part CPPG-26-Buteth-26, PEG-40SOLUBILISANT LR1 / Les2Hydrogenated Castor OilColorant Wackherr SAFragrance (Parfum)Fragrance - BELL #J7393 / Bell0.3Flavors and FragrancesMentholMenthol Crystals, USP0.1Part DButylene Glycol, DeionizedACTIPHYTE OF BLACK0.1water, Black CohoshSNAKEROOT BG50 / Active(Cimicifuga Racemosa) ExtractOrganicsBut...

example 2

Advanced Acne Prone Skin Formulation

[0068] A pharmaceutical composition according to the invention may be prepared for treating skin prone to acne as set forth below:

IngredientTrade Name / Supplier% by WeightPart ADeionized WaterN / A46.7HydroxyethylcelluloseCELLOSIZE1QP52,000H / AmercholPart BTetrasodium Ethylene-Diamine-HAMP-ENE 220 / Akzo Nobel0.1Tetraacetic Acid (EDTA)Butylene Glycol1,3-butylene glycol / Ashland5Aloe Barbadensis GelAloe Vera Freeze Dried0.1Powder 200:1 / AloeMethyl Gluceth-10GLUCAM E-10 / Amerchol3Witch Hazel (HamamelisWitch Hazel Distillate, 14%3Virginiana) DistillateZinc AcetateZinc Acetate, crystals,0.5USP / FCCOrange (Citrus AurantiumNATURAL ORANGE0.3Dulcis) ExtractMethylparabenEXTRACT #71689 / FlavurenceDipotassium GlycyrrhizateN / A0.3Lecithin, Tocopherol andOXYSOMES / Barnett0.3Magnesium Ascorbyl PhosphatePalmitoylGLYCOSPHERE PCO / Kobo0.2HydroxypropyltrimoniumAmylopectin / GlycerinCrosspolymer, Lecithin, Grape(Vitis Vinifera) Seed ExtractPalmitoylGLYCOSPHERE GT / Kobo0.5Hydroxyp...

example 3

Skin Perfecting Lotion

[0070] A pharmaceutical composition according to the invention may be prepared for treating skin as set forth below:

IngredientTrade Name / Supplier% by weightPart AWater (Aqua)Deionized water63.6CarbomerCARBOPOL ULTREZ 10 / 0.3B. F. GoodrichSclerotium GumAMIGEL / Tri-K0.6GlycerinGlycerin 99.5% / Ashland6.0Butylene Glycol1,3-butylene glycol / Ashland6.0AllantoinAllantoin / ISP0.6PanthenolDEXPANTHENOL / Roche0.6Tetrasodium EDTAHAMP-ENE 220 / Akzo0.2MethylparabenMethylparaben / Ueno0.3Sodium PCAAJIDEW-50 / Ajinomoto0.5Part BDicapryl MaleateBERNEL ESTER DCM / Bernel6.0SqualenePHYTOLANE / Barnet0.8Sorbitan StearateARLACEL 60 / ICI1.5Stearic AcidEMERSOL 132 / Henkel1.3DimethiconeDOW CORNING 200, 3500.8cs. / Dow CorningC12-C15 Alkyl BenzoateFINSOLV TN / Finetex3.0Cetearyl Alcohol and CetearethHEXOTOL D / Heterene0.6PropylparabenPropylparaben / Ueno0.2Part CWater (Aqua)Deionized water0.3TriethanolamineTriethanolamine 99% / Ashland0.3Part DOrange (Citrus AurantiumNATURAL ORANGE0.3Dulcis) ExtractEXTRACT #...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
weight percentaaaaaaaaaa
weight percentaaaaaaaaaa
Login to View More

Abstract

This application relates to a stable pharmaceutical composition and methods for the cleaning of skin to facilitate the prevention, treatment, and management of skin conditions, such as seborrheic dermatitis, psoriasis, folliculitis, rosacea, perioral dermatitis, acne, impetigo and other inflammatory skin conditions, and the like, including a sufficient amount of an acidic component of a hydroxyacid or tannic acid, or a pharmaceutically acceptable salt thereof, to exfoliate a portion of the skin, a sufficient amount of stabilized hydrogen peroxide to facilitate cleansing of the skin without substantial irritation thereof, and an antimicrobial agent including at least one of an antibacterial agent, antimicrobial agent, antiviral agent, anthelmintic, or a combination thereof, in an amount sufficient to inhibit or reduce microorganisms on the skin.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation of application Ser. No. 09 / 549,202, filed Apr. 13, 2000, now allowed, which is a continuation-in-part of application Ser. No. 09 / 330,127, filed Jun. 11, 1999, currently U.S. Pat. No. 6,071,541, which is a continuation-in-part of provisional Application No. 60 / 094,775, filed Jul. 31, 1998.TECHNICAL FIELD [0002] This application relates to pharmaceutical compositions and methods to cleanse skin and facilitate the prevention, treatment, and management of skin conditions. BACKGROUND OF THE INVENTION [0003] Human skin is a composite material of the epidermis and the dermis. The topmost part of the epidermis is the stratum corneum. This layer is the stiffest layer of the skin, as well as the one most affected by the surrounding environment. Below the stratum corneum is the internal portion of the epidermis. Below the epidermis, the topmost layer of the dermis is the papillary dermis, which is made of relativ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K33/40A61K31/19A61K8/22A61K8/365A61K8/60A61K8/97A61K45/06A61Q19/00C11D3/20C11D3/48
CPCA61K8/22A61K8/365C11D3/48C11D3/2086A61Q19/00A61K8/602A61K8/97A61K31/19A61K33/40A61K45/06A61K2800/75A61K2300/00A61K8/9789A61K8/9794A61P17/00Y02A50/30
Inventor MURAD, HOWARD
Owner MURAD HOWARD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products